Physician profile
Nicholas Harding
NPI 1023120201
$3,049.14
in general payments reported to CMS, 2019-2025
24 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,100 · 2020: $234 · 2021: $288 · 2022: $288 · 2023: $690 · 2024: $327 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $716 · Travel and Lodging: $422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $715.98 |
| Travel and Lodging | $422.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,672.25 | 2019-2024 | Mako |
| Pacira Pharmaceuticals Incorporated | $188.81 | 2021-2024 | Iovera, Zilretta, Exparel |
| Pacira Therapeutics, INC. | $188.73 | 2019-2021 | |
| Ermi LLC | $162.15 | 2019-2022 | |
| Depuy Synthes Sales INC. | $109.67 | 2020-2025 | Velys, Monovisc |
| Bioventus LLC | $105.63 | 2020-2023 | Durolane |
| Fidia Pharma USA INC. | $70.23 | 2020-2025 | Hymovis, Triluron, Hyalgan |
| Vertex Pharmaceuticals Incorporated | $57.69 | 2025 | |
| Avanos Medical | $53.88 | 2020-2025 | On-Q Pump and Accessories |
| Smith+Nephew, INC. | $47.58 | 2020-2024 | Bone Anchors With Arthroscopic Delivery System |
| Theragen, INC. | $44.63 | 2020-2022 | |
| Abbott Laboratories | $42.58 | 2019 | |
| Boston Scientific Corporation | $41.22 | 2019-2024 | |
| Kowa Pharmaceuticals America, INC. | $39.15 | 2022-2023 | Seglentis |
| Dynasplint Systems INC. | $38.47 | 2023 | Dynasplint |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $35.94 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $34.22 | 2022-2024 | Crysvita |
| Integra Lifesciences Corporation | $24.42 | 2019-2020 | |
| Medtronic, INC. | $18.99 | 2024 | Kyphon Express II Kyphopak Tray |
| Ferring Pharmaceuticals INC. | $16.57 | 2021 | |
| Heron Therapeutics, INC. | $16.17 | 2021 | |
| Trevena, INC. | $15.47 | 2021 | |
| Horizon Therapeutics Plc | $13.29 | 2019 | |
| Zyla Life Sciences, INC. | $11.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Harding listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.